- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04580095
Artificial Intelligence for Improved Echocardiography
Technology Revisiting Ultrasound Solutions of Tomorrow - Artificial Intelligence for Improved Echocardiography
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study population will be recruited from appointed patients at the Clinic of Cardiology, St. Olavs Hospital. After being informed about the study, all patients giving informed consent and meeting the eligibility requirements will undergo their standard clinical echocardiographic exam performed by a sonographer at the clinic. Two additional examinations will then be performed by a different sonographer and an expert cardiologist, respectively.
In one of the study arms the sonographer randomized to perform the second exam will use the AI algorithm (intervention).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Trondheim, Norway, 7491
- St. Olav University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Capacity to consent
Exclusion Criteria:
- Indication for echocardiographic contrast agents
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: With AI algorithm
In the "With AI algorithm" arm, the sonographer will perform the echocardiographic exam using the AI algorithm.
|
The algorithm is based on artificial intelligence, giving the sonographer performing the echocardiographic exam real-time feedback on left ventricular apical foreshortening.The algorithm is developed using deep learning techniques by technologists at the Department of Circulation and Medical Imaging, NTNU.
|
No Intervention: Without AI algorithm
In the "Without AI algorithm", the echocardiographic exam will be performed without the use of the AI algorithm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Left ventricular apical foreshortening
Time Frame: 0 days
|
Apical foreshortening will be evaluated in a blinded manner by echocardiography experts post hoc.
The two study arms will be compared.
|
0 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Image quality
Time Frame: 0 days
|
Image quality will be evaluated in a blinded manner by echocardiography experts post hoc.
A standardized scoring system for image quality in echocardiography developed locally will be utilized for evaluation with score 1-6, where 1 is minimum and 6 is maximum score.
The two study arms will be compared.
|
0 days
|
Inter-observer variation of left ventricular size
Time Frame: 0 days
|
Throughout this study, the sonographers and expert cardiologist will perform measurements based on their individual echocardiographic images.
Differences in measurements will be evaluated to determine inter-observer variation between sonographers and cardiologists.
|
0 days
|
Inter-observer variation of left ventricular function
Time Frame: 0 days
|
Throughout this study, the sonographers and expert cardiologist will perform measurements based on their individual echocardiographic images.
Differences in measurements will be evaluated to determine inter-observer variation between sonographers and cardiologists.
|
0 days
|
Validation of AI algorithm to detect foreshortening
Time Frame: 0 days
|
Comparison of AI algorithm to detect foreshortening with manual reference
|
0 days
|
Inter-observer variation of left atrial size
Time Frame: 0 days
|
Throughout this study, the sonographers and expert cardiologist will perform measurements based on their individual echocardiographic images.
Differences in measurements will be evaluated to determine inter-observer variation between sonographers and cardiologists.
|
0 days
|
Inter-observer variation of left atrial function
Time Frame: 0 days
|
Throughout this study, the sonographers and expert cardiologist will perform measurements based on their individual echocardiographic images.
Differences in measurements will be evaluated to determine inter-observer variation between sonographers and cardiologists.
|
0 days
|
Development of AI algorithm for real-time assessment of left atrium
Time Frame: 0 days
|
Cardiac structures as left atrial (LA) lumen, LA wall, LA appendix, mitral valve will be annotated and used as reference.
|
0 days
|
Variation by methodology
Time Frame: 0 days
|
Variation in measurement by the mode of measurement
|
0 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRUST-AI_201
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Kathirvel SubramaniamUniversity of Maryland, Baltimore; CSL BehringRecruitingHeart Failure,Congestive | Heart Disease End StageUnited States
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Yonsei UniversityCompletedMitral Valvular Heart Disease
-
University College, LondonBritish Heart Foundation; Horizon 2020 - European CommissionRecruitingValvular Heart DiseaseUnited Kingdom
-
Cairo UniversityRecruitingHeart Diseases | Heart Valve Diseases | Open Heart SurgeryEgypt
Clinical Trials on AI algorithm for apical foreshortening in echocardiography
-
Seoul National University HospitalNot yet recruitingLeft Ventricular Systolic Dysfunction
-
Mayo ClinicAnumana, Inc.CompletedCardiac DiseaseUnited States
-
Universitaire Ziekenhuizen KU LeuvenSanten OyCompleted
-
Institut National de la Santé Et de la Recherche...UNITAIDUnknownTuberculosis | Severe Acute MalnutritionZambia, Uganda
-
Ziekenhuis Oost-LimburgRecruiting
-
Eskisehir Osmangazi UniversityCompletedDiagnosis of Pleural DiseasesTurkey
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR)Not yet recruitingSepsis | Bacterial Infections | Community-Acquired Infections | Hospital Infection
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
National Medical Research Center for Children's...RecruitingAortic Valve InsufficiencyRussian Federation
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsUnited States